CN106820129A - 用于糖尿病患者的营养代餐食品 - Google Patents
用于糖尿病患者的营养代餐食品 Download PDFInfo
- Publication number
- CN106820129A CN106820129A CN201710233791.6A CN201710233791A CN106820129A CN 106820129 A CN106820129 A CN 106820129A CN 201710233791 A CN201710233791 A CN 201710233791A CN 106820129 A CN106820129 A CN 106820129A
- Authority
- CN
- China
- Prior art keywords
- parts
- diabetic
- food
- rice
- bean dregs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 55
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 44
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 29
- 235000012054 meals Nutrition 0.000 title claims abstract description 23
- 240000007594 Oryza sativa Species 0.000 claims abstract description 41
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 41
- 235000009566 rice Nutrition 0.000 claims abstract description 41
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 30
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 30
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 25
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 23
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 23
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 21
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 21
- 244000062793 Sorghum vulgare Species 0.000 claims abstract description 21
- 235000020224 almond Nutrition 0.000 claims abstract description 21
- 235000019713 millet Nutrition 0.000 claims abstract description 21
- 240000008042 Zea mays Species 0.000 claims abstract description 20
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims abstract description 20
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 20
- 235000009973 maize Nutrition 0.000 claims abstract description 20
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 6
- 239000002893 slag Substances 0.000 claims description 21
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- 240000004922 Vigna radiata Species 0.000 claims description 11
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 11
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 11
- 244000068988 Glycine max Species 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 abstract description 25
- 239000008280 blood Substances 0.000 abstract description 25
- 235000000346 sugar Nutrition 0.000 abstract description 23
- 239000013589 supplement Substances 0.000 abstract description 11
- 230000035764 nutrition Effects 0.000 abstract description 9
- 235000005911 diet Nutrition 0.000 abstract description 8
- 235000015097 nutrients Nutrition 0.000 abstract description 7
- 235000021152 breakfast Nutrition 0.000 abstract description 6
- 230000000291 postprandial effect Effects 0.000 abstract description 5
- 238000012423 maintenance Methods 0.000 abstract description 4
- 230000003014 reinforcing effect Effects 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 3
- 230000000378 dietary effect Effects 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 239000012190 activator Substances 0.000 abstract 1
- 241000219051 Fagopyrum Species 0.000 description 19
- 230000000694 effects Effects 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 235000016804 zinc Nutrition 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000030136 gastric emptying Effects 0.000 description 2
- 235000001727 glucose Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- CDAISMWEOUEBRE-LKPKBOIGSA-N 1D-chiro-inositol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-LKPKBOIGSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- DINOPBPYOCMGGD-VEDJBHDQSA-N Man(a1-2)Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 DINOPBPYOCMGGD-VEDJBHDQSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- DMASLKHVQRHNES-FKKUPVFPSA-N beta-cryptoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-FKKUPVFPSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- VDTNNGKXZGSZIP-UHFFFAOYSA-N carbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VDTNNGKXZGSZIP-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229930184989 physalin Natural products 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- JKQXZKUSFCKOGQ-QAYBQHTQSA-N zeaxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-QAYBQHTQSA-N 0.000 description 1
- XACHQDDXHDTRLX-HZXCUAKRSA-N zeaxanthin dipalmitate Chemical compound CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-HZXCUAKRSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于糖尿病患者的营养代餐食品,所述食品包括以下组分:糜米、黄米、大米、玉米渣、豆渣、杏仁、燕麦片、荞麦仁、枸杞;通过上述组分形成适用于糖尿病患者的特殊营养结构体系,增强适用于患者的营养定向性,含有丰富且具有指向性的生理活性物质,调整人体机能,能够促进机体功能的自我调理,并对体内缺乏的营养元素有强化性的补充,能够对糖尿病患者血糖水平的维持起到一定的辅助作用,保持餐后血糖的平稳,在对机体补充所需营养的同时能维持患者的标准体重水平,对糖尿病患者具有一定的保健功能,适合糖尿病患者三餐食用。
Description
技术领域
本发明涉及食品领域,特别涉及一种用于糖尿病患者的营养代餐食品。
背景技术
糖尿病是一种由于体内胰岛素的绝对或相对分泌不足而引起的以糖代谢紊乱为主的全身性疾病。临床主要表现为多饮、多食、多尿、消瘦乏力等症状。糖尿病属中医消渴、消瘅范畴,中医认为主要成因有饮食不节、情志失调和肾阴亏损三个方面;消渴病变与五脏均有关,尤以肾为重。现代医学技术还没有发现彻底治疗糖尿病的有效手段,目前的临床处理多是以药物控制为主,以饮食控制配合来控制病情的发展。控制饮食的目的主要是控制每餐饮食中还原糖、还原糖源的摄入量以及糖类在体内消化吸收的速度,并选用能辅助降低血糖的食物,同时补充因不能正常进食各种食物而导致或可能导致缺失的营养素,如蛋白质、膳食纤维、VB1、VB6、VC、钙、锌、硒及镁等。目前有多种适合于糖尿病的保健食品或营养粉,适合糖尿病患者食用但不能或不足于补充因控制饮食而缺失的多种营养物质;往往是以降低血糖为主要诉求;忽视了患者因为饮食控制而需要补充的营养物质。
发明内容
有鉴于此,本发明的目的在于提供一种用于糖尿病患者的营养代餐食品,能够促进机体功能的自我调理,并对体内缺乏的营养元素有强化性的补充,能够对糖尿病患者血糖水平的维持起到一定的辅助作用,保持餐后血糖的平稳,在对机体补充所需营养的同时能维持患者的标准体重水平,对糖尿病患者具有一定的保健功能,适合糖尿病患者三餐食用。
本发明的用于糖尿病患者的营养代餐食品,所述食品包括以下组分:糜米、黄米、大米、玉米渣、豆渣、杏仁、燕麦片、荞麦仁、枸杞;
进一步,所述食品按重量份包括以下组分:
糜米20-50份、黄米5-20份、大米10-40份、玉米渣5-35份、豆渣3-15份、杏仁1-15份、燕麦片1-15份、荞麦仁2-20份、枸杞0.1-3份;
进一步,所述食品按重量份包括以下组分:
糜米25-40份、黄米5-15份、大米15-35份、玉米渣8-30份、豆渣3-10份、杏仁1-10份、燕麦片2-12份、荞麦仁2-15份、枸杞0.1-2份;
进一步,所述食品按重量份包括以下组分:
糜米30份、黄米10份、大米25份、玉米渣15份、豆渣6份、杏仁3份、燕麦片6份、荞麦仁5份、枸杞0.3份;
进一步,所述豆渣为黑豆渣、绿豆渣中的一种或两种。
本发明的有益效果:本发明的用于糖尿病患者的营养代餐食品,能够促进机体功能的自我调理,并对体内缺乏的营养元素有强化性的补充,能够对糖尿病患者血糖水平的维持起到一定的辅助作用,保持餐后血糖的平稳,在对机体补充所需营养的同时能维持患者的标准体重水平,对糖尿病患者具有一定的保健功能,适合糖尿病患者三餐食用。
糜米,具有芦丁、槲皮素、D-手性肌醇等生理功能因子,能有效地调节血糖,改善糖尿病人症状。
黄米,黄米富含蛋白质、碳水化合物、B族维生素、维生素E、锌、铜、锰等营养元素,具有益阴、利肺、利大肠之功效。
杏仁,含有丰富的单不饱和脂肪酸等微量元素,维生素E、蛋白质、膳食纤维、锌、钙、镁等微量元素,补充均衡的营养,同时有助于维持饱腹感,有利于控制体重,维持健康的血糖水平。
燕麦片,因其高纤维和低血糖指数,可以帮助调节血糖并维持血糖的健康水平,能够很好的管控血糖水平,还能降低患者对胰岛素的需求量,并促进心脏健康。另外,它是高纤维食物,延长饱腹感的时间,帮助控制体重。
荞麦仁,荞麦中铬和矾的含量较高,这两种微量元素具有明显的降血糖作用,含氨基酸为7%~13%荞麦中含有脂肪20%~30%,脂肪中含有9种脂肪酸,其中最多的是油酸和亚油酸油酸在人的身体内可以合成落花生四烯酸,具有降低血脂的作用荞麦含有多种微量元素,含有的维生素b1和b2比小麦多2倍,烟酸多3倍~4倍荞麦中还含有其他食物所不具有的芸喷鼻甙烟酸和芸喷鼻甙有降低血脂的作用。
枸杞,含甜菜碱、酸浆果红素、玉蜀黍黄素、隐黄质、天仙子胺及多种维生素如胡萝卜素、维生素B1、B2、C等,此外还含有多种微量元素和氨基酸等活性成分,药理研究结果证实,枸杞子有降血糖作用。动物实验研究发现,宁夏枸杞提取物可引起大鼠血糖显着而持久降低,碳水化合物耐量升高,并认为其降血糖作用乃由于其中含有胍的衍生物。枸杞及其多糖制剂对损害的胰岛B细胞或受体具有保护和修复作用,对人体免疫力具有调解或增强作用。此外,还发现枸杞子有降血压,降血脂,保护肝脏的作用,并有轻度抑制脂肪在肝细胞内沉积和促进肝细胞新生的作用。临床常用于治疗糖尿病肝肾阴虚者、2型糖尿病肥胖者及糖尿病并发症如视网膜病变、高血压、高血脂、冠心病等。
本发明的用于糖尿病患者的营养代餐食品,并不是各组分的简单叠加,该代餐食品,重点突出于种类的选择和搭配以及各组分之间的特殊配比关系,各组分之间协同作用,使其在补充患者机体营养的同时,又能维持餐后的健康血糖水平,保持患者的正常体重,同时增强患者机体自身的免疫力。虽然现有技术中,对血糖有调控作用的药食同源的物质很多,有利于糖尿病人的食物也很多,但是,不同的物质因自身理化性质的不同,最终导致作用效果不同,例如:实膳食纤维食品和低碳水化合物膳食可降低餐后血清胰岛素的水平。膳食纤维也会因分子结构、分子量等理化性质的原因,而在吸水性、黏度等方面有所差异,并对其减缓葡萄糖扩散、吸附和降低仅淀粉酶催化活力等功能有所影响。不同的膳食纤维对血糖的控制效果不同。
具体实施方式
本实施例的用于糖尿病患者的营养代餐食品,所述食品包括以下组分:糜米、黄米、大米、玉米渣、豆渣、杏仁、燕麦片、荞麦仁、枸杞;通过上述组分形成适用于糖尿病患者的特殊营养结构体系,增强适用于患者的营养定向性,含有丰富且具有指向性的生理活性物质,调整人体机能,延长胃的排空和肠道运送速度,延缓食物中碳水化合物的摄取,对体内缺乏的营养元素有强化性的补充,能够对糖尿病患者血糖水平的维持起到一定的辅助作用,保持餐后血糖的平稳,在对机体补充所需营养的同时能维持患者的标准体重水平。
本实施例中,所述食品按重量份包括以下组分:
糜米20-50份、黄米5-20份、大米10-40份、玉米渣5-35份、豆渣3-15份、杏仁1-15份、燕麦片1-15份、荞麦仁2-20份、枸杞0.1-3份;营养素配比合理,有效避免长期饮食限制导致的营养不良,精确控制患者的能量摄入,有效控制碳水化合物、蛋白质和脂肪的比例,达到饮食均衡的目的,使其适用于所有的糖尿病患者。
本实施例中,所述食品按重量份包括以下组分:
糜米25-40份、黄米5-15份、大米15-35份、玉米渣8-30份、豆渣3-10份、杏仁1-10份、燕麦片2-12份、荞麦仁2-15份、枸杞0.1-2份;该配比更能体现针对糖尿病患者的营养的定向性,代谢负担更低,通过在配比上的优化和调整,更长的延迟胃排空,降低小肠中食物的消化率。
本实施例中,所述食品按重量份包括以下组分:
糜米30份、黄米10份、大米25份、玉米渣15份、豆渣6份、杏仁3份、燕麦片6份、荞麦仁5份、枸杞0.3份。
本实施例中,所述豆渣为黑豆渣、绿豆渣中的一种或两种。
下面通过具体实施例对本发明做进一步的阐述。
实施例一
本实施例中,所述食品按重量份包括以下组分:
糜米30份、黄米10份、大米25份、玉米渣15份、豆渣6份、杏仁3份、燕麦片6份、荞麦仁5份、枸杞0.3份。
本实施例中,所述豆渣为黑豆渣和绿豆渣,黑豆渣和绿豆渣按1:1的配比。
实施例二
本实施例的用于糖尿病患者的营养代餐食品,所述食品按重量份包括以下组分:
糜米20份、黄米5份、大米10份、玉米渣5份、豆渣3份、杏仁1份、燕麦片1份、荞麦仁2份、枸杞0.1份。
本实施例中,所述豆渣为黑豆渣和绿豆渣,黑豆渣和绿豆渣按1:1的配比。
实施例三
本实施例的用于糖尿病患者的营养代餐食品,所述食品按重量份包括以下组分:
糜米50份、黄米20份、大米40份、玉米渣35份、豆渣15份、杏仁15份、燕麦片15份、荞麦仁20份、枸杞3份。
本实施例中,所述豆渣为黑豆渣。
实施例四
本实施例的用于糖尿病患者的营养代餐食品,所述食品按重量份包括以下组分:
糜米20份、黄米20份、大米30份、玉米渣5份、豆渣15份、杏仁12份、燕麦片1份、荞麦仁20份、枸杞1份。
本实施例中,所述豆渣为绿豆渣中。
实施例五
本实施例的用于糖尿病患者的营养代餐食品,所述食品按重量份包括以下组分:
糜米25份、黄米5份、大米15份、玉米渣8份、豆渣3份、杏仁1份、燕麦片2份、荞麦仁2份、枸杞0.1份。
本实施例中,所述豆渣为黑豆渣和绿豆渣,按1:1配比。
实施例六
本实施例的用于糖尿病患者的营养代餐食品,所述食品按重量份包括以下组分:
糜米40份、黄米15份、大米35份、玉米渣30份、豆渣10份、杏仁10份、燕麦片12份、荞麦仁15份、枸杞2份。
本实施例中,所述豆渣为黑豆渣和绿豆渣,按1:1配比。
实施例七
本实施例的用于糖尿病患者的营养代餐食品,所述食品按重量份包括以下组分:
糜米25份、黄米15份、大米15份、玉米渣30份、豆渣6份、杏仁2份、燕麦片2份、荞麦仁15份、枸杞0.1份。
本实施例中,所述豆渣为绿豆渣。
上述实施例中,还可加入1-3份的坚果以延迟胃排空,降低小肠中食物的消化率,3-6份的南瓜粉,起到降血糖的作用,也可加入0.1-1份的甜味剂以改善口感,可以选择甜味素、安赛甜、甘草甜素、氯化蔗糖、结晶果糖、大豆寡糖、木糖醇、山梨醇和麦芽糖醇等中的一种,还可加入铬酵母0.1-0.18份、黑麦精1.5-2.5份,莜麦面5-15份。
实验例
1.对象与方法:研究对象符合WTO(1999)糖尿病诊断标准、自愿、意识清楚、具备正常交流能力,目前正接受药物治疗且病情相对稳定、无严重并发症的2型糖尿病患者30例。其中男9例,女21例,年龄48~82岁,平均年龄(65.5±10.5)岁,平均病程(8.3±6.3)年。
2.所有受试者用德国拜耳公司的拜安捷微量血糖仪检测空腹血糖,根据患者标准体重以早餐热量占全天总热量的1/5计算出每例患者的早餐能量需要。所有早餐以身高165cm,标准体重60kg的轻体力劳动者早餐需要能量设定,具体根据病人的情况适当增减。按20千卡/公斤体重能量计算。所有患者进食后静坐,2h后再次测血糖。
3.统计学处理用SPSS软件10.0进行分析,各参数用均值±标准差(x+s)表示,统计方法包括方差分析、χ2检验、t检验,以P﹤0.05为差异有显著性
4.结果各组年龄、体重指数及空腹血糖、餐后2小时血糖比较(见表)。
最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的宗旨和范围,其均应涵盖在本发明的权利要求范围当中。
Claims (5)
1.一种用于糖尿病患者的营养代餐食品,其特征在于:所述食品包括以下组分:糜米、黄米、大米、玉米渣、豆渣、杏仁、燕麦片、荞麦仁、枸杞。
2.根据权利要求1所述的用于糖尿病患者的营养代餐食品,其特征在于:所述食品按重量份包括以下组分:
糜米20-50份、黄米5-20份、大米10-40份、玉米渣5-35份、豆渣3-15份、杏仁1-15份、燕麦片1-15份、荞麦仁2-20份、枸杞0.1-3份。
3.根据权利要求2所述的用于糖尿病患者的营养代餐食品,其特征在于:所述食品按重量份包括以下组分:
糜米25-40份、黄米5-15份、大米15-35份、玉米渣8-30份、豆渣3-10份、杏仁1-10份、燕麦片2-12份、荞麦仁2-15份、枸杞0.1-2份。
4.根据权利要求3所述的用于糖尿病患者的营养代餐食品,其特征在于:所述食品按重量份包括以下组分:
糜米30份、黄米10份、大米25份、玉米渣15份、豆渣6份、杏仁3份、燕麦片6份、荞麦仁5份、枸杞0.3份。
5.根据权利求1所述的用于糖尿病患者的营养代餐食品,其特征在于:所述豆渣为黑豆渣、绿豆渣中的一种或两种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710233791.6A CN106820129A (zh) | 2017-04-11 | 2017-04-11 | 用于糖尿病患者的营养代餐食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710233791.6A CN106820129A (zh) | 2017-04-11 | 2017-04-11 | 用于糖尿病患者的营养代餐食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106820129A true CN106820129A (zh) | 2017-06-13 |
Family
ID=59146730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710233791.6A Pending CN106820129A (zh) | 2017-04-11 | 2017-04-11 | 用于糖尿病患者的营养代餐食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106820129A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109198399A (zh) * | 2018-08-06 | 2019-01-15 | 上海溯焕实业有限公司 | 一种降血糖的食品组合物 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1144050A (zh) * | 1995-01-24 | 1997-03-05 | 北京恒明技术开发中心 | 降糖功能食品 |
CN1378795A (zh) * | 2002-05-15 | 2002-11-13 | 薛万坤 | 具有浓郁香味的甜窝头及其生产方法 |
CN1586305A (zh) * | 2004-09-27 | 2005-03-02 | 广西大学 | 一种膳食纤维及其生产方法 |
CN101874615A (zh) * | 2009-04-29 | 2010-11-03 | 陈艳端 | 可降低糖尿病人餐后血糖的食品的生产方法 |
CN102485040A (zh) * | 2010-12-01 | 2012-06-06 | 张宏丽 | 一种降血糖、降血压保健营养粉 |
CN103461833A (zh) * | 2012-06-06 | 2013-12-25 | 重庆市彭水县彭双科技有限公司 | 保健燕麦粉的生产工艺 |
-
2017
- 2017-04-11 CN CN201710233791.6A patent/CN106820129A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1144050A (zh) * | 1995-01-24 | 1997-03-05 | 北京恒明技术开发中心 | 降糖功能食品 |
CN1378795A (zh) * | 2002-05-15 | 2002-11-13 | 薛万坤 | 具有浓郁香味的甜窝头及其生产方法 |
CN1586305A (zh) * | 2004-09-27 | 2005-03-02 | 广西大学 | 一种膳食纤维及其生产方法 |
CN101874615A (zh) * | 2009-04-29 | 2010-11-03 | 陈艳端 | 可降低糖尿病人餐后血糖的食品的生产方法 |
CN102485040A (zh) * | 2010-12-01 | 2012-06-06 | 张宏丽 | 一种降血糖、降血压保健营养粉 |
CN103461833A (zh) * | 2012-06-06 | 2013-12-25 | 重庆市彭水县彭双科技有限公司 | 保健燕麦粉的生产工艺 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109198399A (zh) * | 2018-08-06 | 2019-01-15 | 上海溯焕实业有限公司 | 一种降血糖的食品组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102113648A (zh) | 一种适合“五高”代谢综合症人群的特膳面条及其制备方法 | |
CN104286849A (zh) | 一种糖尿病专用型肠内营养多聚合剂 | |
CN101347193A (zh) | 能够提供均衡营养的复合米及其制作工艺 | |
CN104544432A (zh) | 一种翅果油复合蛋白固体饮料及其制备方法 | |
CN110663872A (zh) | 一种全营养代餐减肥食品、制备方法及食用方法 | |
CN103168812A (zh) | 一种无蔗糖苦荞饼干及其制作方法 | |
CN102783636A (zh) | 一种防治糖尿病食品的营养补充剂及其应用 | |
CN109198641A (zh) | 一种低碳水化合物含量的食品配方及由其制备的防弹咖啡 | |
CN101816317A (zh) | 一种具有降糖降脂功能的营养饼干 | |
CN102113652A (zh) | 一种适合“五高”代谢综合症人群的特膳挤压米及其制备方法 | |
CN108175089A (zh) | 一种适用于糖尿病患者的全营养配方液 | |
GOLDSMITH et al. | Studies of niacin requirement in man: III. Comparative effects of diets containing lime-treated and untreated corn in the production of experimental pellagra | |
CN106135791A (zh) | 一种强化营养的降糖特膳即食谷物粉 | |
CN105407740A (zh) | 给予食物组合物产品 | |
CN111213690A (zh) | 一种低gi鹰嘴豆淀粉面包的配方及其制备方法 | |
CN106858578A (zh) | 适于糖尿病患者食用的营养面粉 | |
US20140314942A1 (en) | Method of transforming a meal | |
CN108703378A (zh) | 一种糖尿病型肠内营养多聚合剂 | |
CN106820129A (zh) | 用于糖尿病患者的营养代餐食品 | |
CN112352955A (zh) | 一种基于生酮原理干预多囊卵巢综合症的低gi全营养代餐粉及其应用 | |
EP2294932B1 (en) | Carbohydrate mixture and the use thereof for preparing a product for oral or enteral nutrition | |
Kinmonth et al. | Dietary recommendations for children and adolescents with diabetes | |
CN110101020A (zh) | 一种糖尿病全营养素配方食品 | |
Agrawal et al. | Managing diabetes mellitus with millets: A new solution | |
CN101524153A (zh) | 益于糖尿病人的保健小麦面粉 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170613 |
|
RJ01 | Rejection of invention patent application after publication |